Such VEGFR2/NRP1 trans‐complexes arrest VEGFR2 on the endothelial cell surface, interfering with productive signaling, for example, in the extracellular regulated kinase (ERK) pathway 13, ultimately resulting in suppressed tumor angiogenesis, reduced tumor cell proliferation, and prolonged patient survival. Here, KDR is linked to neoplasm.